ABCL

#1697
AbCellera Biologics Inc. - Common Shares
6.1 8 USD
+7.85%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
6.05
6.22
Jahresspanne
1.98
6.52
Tagesänderung
+7.85%
Monatliche Änderung
+59.28%
6 month change
+71.19%
Jahresänderung
+202.94%
Vorheriger Schlusskurs
5.7 3
Open
6.0 6
Tief
6.0 5
High
6.2 2
Volumen
1 579
Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Nachrichten